CEACAM5 and pancreatic neoplasm: However, when compared to previous work performed using the same hM5A-IR800 and a CEA-positive human pancreatic cancer cell line, BxPC3, the pancreatic cancer PDOX model showed 8-fold lower overall fluorescence intensity values and 4-fold lower contrast at 48 hours [21].